1 Major Crossmatch versus Type&Screen : Why to choose for Type&Screen Major Vandenvelde Christian, Physician – Biologist, Head of Military Service for.

Slides:



Advertisements
Similar presentations
Dr. Mohammed H Saiemaldahr BLOOD BANK MED TECH
Advertisements

COMPATIBILITY TESTING
When can you use an antibody to find another antibody?
Hemolytic Disease of the Newborn Case #3
1 ISBT 128 Industry Standard and Implementation Process Overview.
Transfusion Medicine, BCSH
Prepared By: Miss. Sana’a AL-Sulami. Outlines: What is the blood transfusion. Purpose of blood transfusion. Assessment of the patient. Planning for blood.
Transfusion Quiz. Q1. What colour blood tube is used for a group and cross match sample? Red Purple Pink Grey.
Blood Components Dosage And Their Administration
Competency/Training and CLIA
Blood Bank/Transfusion Committee Tutorial Marc Zumberg MD The Shands Transfusion Committee November 2007.
Treviso, 21 October Karin Magnussen. Donors outside the Blood Bank /Centre Donors in the Blood Bank /Centre Blood products Blood Group serology The Patients.
ABO Blood Group System. Importance of ABO system ABO compatibility between donor cell and patient serum is the essential foundation of pre-transfusion.
Immunohematology (Blood Bank) CLS 245. What is Immunohematology? It is the study of Antigen-Antibody reaction as they relate to blood disorder.
Detection and Identification of alloantibodies to Red Cell Antigens
Blood bank Manager Login Page
Case Study #1 Marilyn Telen, MD Duke University.
ABO/D Blood Groups Understanding Critical For Safe Transfusions.
Right Patient, Right Blood
+ Dr. Megan Rowley Consultant in Transfusion Medicine Blood Transfusion.
Antibody Screening / Detection & Antibody Identification
IN THE NAME OF GOD Blood Safety S. AMINI KAFI ABAD CLINICAL AND ANATOMICAL PATHOLOGIST IRANIAN BLOOD TRANSFUSION ORGANIZATION(IBTO) RESEARCH CENTER June.
Antibody Screening and Identification
INCOMPLETE CROSSMATCH
Compatibility Testing (cross matching)
GMP on blood/plasma collection establishments Group 2.
IN THE NAME OF GOD Quality Assurance and Blood Bank S. AMINI KAFI ABAD CLINICAL AND ANATOMICAL PATHOLOGIST IRANIAN BLOOD TRANSFUSION ORGANIZATION(IBTO)
Compatibility Testing
TRANSPORT IN PLANTS AND ANIMALS BLOOD GROUPS AND BLOOD TRANSFUSION Lesson objectives; By the end of the lesson the learner should be able to explain the.
Module 1: The Journey of Blood: Donation to Distribution Transfusion Training Workshop KKM 2012.
Pretranfusion Compatibility Testing Mr. Mohammed A. Jaber.
Human Blood Typing Lab Objective: 1. Apply blood typing method to determine the blood type for a sample of synthetic human blood 2. Describe the appearance.
Antibody Detection & Identification Review
ABO Blood Grouping Name: Class: Date: Who Can Donate to Whom? Use the information on the left side of the below diagram to draw arrows from the donor to.
Blood Groups and Transfusions. Blood Loss Body is only able to compensate for minor losses – 15-30% cause weakness – >30% body goes into shock Can be.
Compatibility Testing practical NO 4 Dr: Dalia Kamal Eldien.
Serological Testing In Blood Transfusion Services
Terry Kotrla, MS, MT(ASCP)BB Unit 8 Pretransfusion Testing Part 1.
lecture 10 blood bank Compatibility Testing
Blood Component Testing and Labeling. Each donor unite must be tested and properly labeled before its release for transfusion. Required Tests: In most.
Part III. Essentials of Pretransfusion Testing.
New policy starts 5th April 2016 IMPORTANT CHANGE TO BLOOD TRANSFUSION SAMPLE REQUIREMENTS Confirmation of a blood group from two samples taken on separate.
Unit #6F – Clinical Laboratory Testing – Basic Immunohematology Cecile Sanders, M.Ed., MT(ASCP), CLS (NCA)
Immunohematology. The study of the human ( ) Includes: – Evaluation of blood donors – Collection and processing of donor blood – Testing patient blood.
What are the classes of human blood groups based on? Pgs  Be sure to discuss the antigens and antibodies present in blood and how they differ.
Reagents and Methods for Testing in the Blood Bank
Techniques for Emergency Compatibility Testing
Cross-matching as part of Pre transfusion compatibility
Compatibility Testing
1. A man heterozygous for Type B blood and a woman with Type O blood decide to have children. What is the probability of them having universal blood donors.
If you’re in an accident and need blood, how do you know which blood type you could receive from a donor?
Assist. Prof.Dr. Sajeda Al-Chalabi
ABO Discrepancies: A common challenge faced by Blood Transfusion staff Pruthvi Raj, Manish Raturi, Shamee Shastry, Poornima Baliga B. DEPARTMENT OF IMMUNOHEMATOLOGY.
This schematic depicts the steps taken to type, screen, and crossmatch blood. To determine ABO group and rhesus type, commercial anti-A, anti-B, anti-Rh(D)
Pretranfusion Compatibility Testing Mr. Mohammed A. Jaber.
Manitoba Report for NAC October 15,
Antibody Screening tutorial Discuss the importance of antibody screening. Describe characteristics of antibody screening cells. Describe the antibody.
Unit #5F – Clinical Laboratory Testing – Basic Immunohematology
Detection and Identification of alloantibodies to Red Cell Antigens
RED BLOOD CELLS.
Trace Line Project Realizations NAC Meeting
Transfusion Medicine Kristine Krafts, M.D..
Intraoperative Cell Salvage
“There’s a resident, do we crossmatch for an A1?”
19-3 Blood Types Surface antigens
Pretranfusion Compatibility Testing
LabCraft A complete IT system for Blood banks and transfusion service.
SIGNIFICANCE OF DETECTION AND RESOLUTION OF BLOOD GROUP DISCREPANCIES
Blood Typing.
Presentation transcript:

1 Major Crossmatch versus Type&Screen : Why to choose for Type&Screen Major Vandenvelde Christian, Physician – Biologist, Head of Military Service for Blood Transfusion, Head of Brugmann U.H.C. / Queen Fabiola Children U.H.C. / C.T.R. / Heysel R.C. Immuno - Haematology Laboratory

2 What is a Major Crossmatch ?  Compatible RBC Bag(s) request →  Patient RBC ABO-D(-CcEe)(-K) Typing →  Typing-compatible RBC Bag(s) selection →  Bag(s) RBC crossmatching with Patient plasma → –Bag(s) RBC compatible with Patient plasma → RBC Bag(s) reservation for Patient –What if positive Major Crossmatch ?

3 What is a Type&Screen ?  Compatible RBC Bag(s) request →  Patient RBC ABO-D(-CcEe)(-K) Typing + Patient plasma Screening for Irregular anti-RBC Ab by “crossmatching” with commercially available selected 3-RBC- panel(s) → –Patient plasma negative IAT → Typing-compatible RBC Bag(s) selection when needed –What if positive IAT ?

4 What if positive MXM / IAT ?  Positive MXM → –Either : further Bag(s) RBC Crossmatching with Patient plasma –Or : Patient plasma Screening for Irregular anti- RBC Ab → …  Positive IAT → –Irregular anti-RBC Ab Identification with commercially available 11-RBC-panel(s) → Typing- & Identification-compatible RBC Bag(s) selection when needed What if available Bag(s) RBC were not phenotyped for concerned Ag ? What if Patient anti-RBC Ab remain(s) unidentified ?

5 What if unidentified Patient Ab / non-phenotyped Bag(s) RBC Ag ?  Available Typing-compatible Bags RBC Crossmatching with Patient plasma  Available Typing-compatible Bags RBC phenotyping for concerned Ag  Typing- / Identification-compatible RBC Bag(s) searching by B.T.C. in : –national BTI RBC Bags stocks –international BTI Frozen-Phenotyped-RBC Bags stocks

6 PRELIMINARY CONCLUSION  Most of the time the right question will be : “Why to choose either for MXM or for T&S as FIRST RBC compatibility test ?”  4 Ways to go : –MXM only → Example : Q.A.M.H. Blood Bank –T&S only → Example : Military Ops Support –First T&S, then MXM → Example : Brugmann U.H.C. (Laeken + Schaerbeek + Jette sites) / Queen Fabiola Children U.H.C. / Centre for Traumatology & Rehabilitation / Heysel Rehabilitation Centre Blood Bank –First MXM, then T&S → Example(s) : cfr previous presentation

7 Type&Screen resources constraints  Reagents : commercially available Screening RBC-panels are expensive but →  Technologists : Screening procedures are easy to automate but →  Equipments : Screening automates are expensive but →  RBC Bags stock : Screening allows –an average RBC Bags stock reduction of +/- 33% –an average RBC Bags expiry rate reduction of +/- 95%, especially when a M.S.B.O.S. has been successfully implemented, but →

8 Type&Screen Patient risks  Screening misses 1 allo-Ab per 3000 RBC compatibility tests but →  Screening misses 1 weakly-reactive potentially clinically significant allo-Ab per RBC compatibility tests but →  Screening-missed allo-Ab likely would not result in life-threatening reactions but →  Screening misses clerical ABO-compatibility RBC Bags selection / labelling errors but →  Screening is mandatory followed by an ABO- compatibility check but →  Screening misses allo-Ab present in residual plasma of RBC Bags but →  National BTIs have to warrant the absence of clinically significant allo-Ab in produced L.B.C.

9 MXM only : Burn Unit Q.A.M.H. Blood Bank support  Reagents & Equipments : –no de novo allo-Ab in 13 years –3 allo-Ab at admission in 13 years –+/- 66% of requested RBC Bags are transfused  Technologists : –no experience in allo-Ab identification –1 MXM for 2 RBC Bags from same apheresis donor –presence required for other lab tasks  RBC Bags stock : 2 times the average number of transfused RBC Bags  Patients risks : ABO-D-CcEe-Kk-compatible RBC Bags are electronically selected

10 T&S only : Military Ops Q.A.M.H. Blood Bank support  Reagents, Technologists & Equipments : –Screening before departure makes field-lab compatibility testing useless –Screening-positive soldiers remain in Belgium (0.01%)  RBC Bags stock : 20 refrigerated frozen O Rh/K-negative RBC Bags are continuously available  Patients risks : –O Rh/K-negative RBC Bags are “universal” –RBC Bags are systematically tested for auto- & allo- Ab –Donor Typing occurs at least 2 times before first donation

11 First T&S, then MXM : Brugmann Blood Bank resources constraints  Reagents : unusually high frequency of allo- immunised, polytransfused & multipregnancy patients  Technologists : –important experience in allo-Ab identification –4 years ago, 15% of requested RBC Bags were transfused  Equipments : 4 years ago, unusually high frequency of RBC Bags requests  RBC Bags stock : after 4 years, RBC Bags needs & expiry rates have already been reduced by 33% & 85%, respectively

12 First T&S, then MXM : Brugmann Blood Bank risks management  Extended phenotyping of haematology / oncology patients at first admission  As extended as possible electronic-crossmatch for haematology / oncology / childbearing patients  Maximal use of ABO-D-CcEe-Kk-DAT-IAT screened RBC Bags  Maximal availability of extendedly phenotyped RBC Bags  ABO-compatibility check at patient’s bed

13 FINAL CONCLUSION  QUESTION : “Why to choose either for Major Crossmatch or for Type & Screen as (FIRST) RBC compatibility test ?”  ANSWER : “It only depends on hospital blood bank human and material resources and patients risks management capabilities”